12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
Clinical trial NCT01843348 · COMPLETED
Trial details
- NCT number
- NCT01843348
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-27
- Primary completion
- 2016-03-23
- Enrollment
- 612
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.